MiNK Therapeutics, Inc. (INKT): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$73.6K
Year ended 2023-12-31
-8.2%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $73.6K | -70.6% | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | $250.0K | +0.4% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $249.0K | +161.5% | 2023-03-24, From 2021-01-01 |
| 2020-12-31 | $95.2K | n/a | 2022-03-18, From 2020-01-01 |